Skip to main content
Premium Trial:

Request an Annual Quote

Sony DADC, Axela Partner on Smart Consumables

NEW YORK (GenomeWeb News) – Sony DADC and Axela today announced they are partnering to develop and manufacture smart consumables for Axela's dotLab mX detection system.

The platform combines diffractive optics technology and label-free sensing for the real-time detection of binding events and "full characterization of biomarkers through sequential probing," the companies said, adding that the resulting dynamic range and panel flexibility "is unachievable with any other commercially available product."

The partnership is expected to accelerate Axela's expansion into applied testing and diagnostics from the research markets, Axela COO Paul Smith said in a statement.

Alex Izmailov, vice president of product development and manufacturing for the Toronto-based firm added, "Sony DADC's precision sensors in combination with the inherent self-referencing properties of diffractive optics will make our system highly attractive not only for biomarker screening and assay development but also as the method of choice for robust, routine analysis."

Terms of the deal were not disclosed.

Today's announcement follows Sony DADC's deal with Maven Biotechnologies last week, also to develop and manufacture smart consumables.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.